NJ State Employees Deferred Compensation Plan’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-30,000
Closed -$965K 499
2022
Q1
$965K Hold
30,000
0.13% 169
2021
Q4
$793K Hold
30,000
0.1% 208
2021
Q3
$692K Hold
30,000
0.09% 228
2021
Q2
$789K Hold
30,000
0.1% 212
2021
Q1
$670K Hold
30,000
0.1% 233
2020
Q4
$588K Hold
30,000
0.09% 227
2020
Q3
$421K Hold
30,000
0.08% 254
2020
Q2
$340K Hold
30,000
0.06% 294
2020
Q1
$189K Hold
30,000
0.04% 378
2019
Q4
$610K Hold
30,000
0.1% 209
2019
Q3
$499K Hold
30,000
0.09% 243
2019
Q2
$493K Buy
30,000
+8,574
+40% +$165K 0.09% 271
2019
Q1
$376K Buy
21,426
+4,426
+26% +$94.2K 0.07% 360
2018
Q4
$422K Buy
+17,000
New +$565K 0.09% 270

Other funds holding TVTY

NJ State Employees Deferred Compensation Plan's TVTY Position: Q2 2022 in Review

NJ State Employees Deferred Compensation Plan sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 30,000 shares — an estimated $965K sold.

NJ State Employees Deferred Compensation Plan first reported a position in TVTY in Q4 2018 and held it in 14 quarters. The position peaked at $965K in Q1 2022. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • NJ State Employees Deferred Compensation Plan reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 30,000 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $965K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Tivity Health, Inc. Common Stock in Q4 2018 and held it in 14 quarters.
  • NJ State Employees Deferred Compensation Plan's Tivity Health, Inc. Common Stock position peaked at $965K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2022, filed 1 Aug 2022.